Current progress in using vitamin D and its analogs for cancer prevention and treatment
- PMID: 22716497
- DOI: 10.1586/era.12.53
Current progress in using vitamin D and its analogs for cancer prevention and treatment
Abstract
Vitamin D has long been known for its physiological role in mineral homeostasis through its actions on the intestines, kidneys, parathyroid glands and bone. However, recent observations of antiproliferative, prodifferentiating and antiangiogenic effects elicited by the bioactive form of vitamin D (1,25[OH](2)D(3)) in a broad range of cancers is less well understood. Here, we review the increasing epidemiological and experimental evidence that supports the development of 1,25(OH)(2)D(3) and vitamin D analogs as preventative and therapeutic anticancer agents. Furthermore, this review summarizes the preclinical and clinical studies of vitamin D and its analogs over the past decade, indicating the current problems of dose-limiting toxicity from hypercalcemia and large interpatient variability in pharmacokinetics. A better understanding of how genetic variants influence vitamin D status should not only improve cancer risk predictions, but also promote the development of vitamin D analogs with more specific actions to improve therapeutic outcomes.
Similar articles
-
Vitamin D analogs: therapeutic applications and mechanisms for selectivity.Mol Aspects Med. 2008 Dec;29(6):433-52. doi: 10.1016/j.mam.2008.04.001. Epub 2008 May 1. Mol Aspects Med. 2008. PMID: 18554710 Review.
-
Vitamin D compounds: clinical development as cancer therapy and prevention agents.Anticancer Res. 2006 Jul-Aug;26(4A):2551-6. Anticancer Res. 2006. PMID: 16886663
-
Vitamin D analogs in cancer prevention and therapy.Anticancer Res. 2006 Jul-Aug;26(4A):2511-4. Anticancer Res. 2006. PMID: 16886658
-
Cancer chemoprevention using natural vitamin D and synthetic analogs.Annu Rev Pharmacol Toxicol. 2001;41:421-42. doi: 10.1146/annurev.pharmtox.41.1.421. Annu Rev Pharmacol Toxicol. 2001. PMID: 11264464 Review.
-
Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.CMAJ. 1996 Oct 1;155(7):955-61. CMAJ. 1996. PMID: 8837546 Free PMC article. Review.
Cited by
-
BRAF signals to pro-apoptotic BIM to enhance AraC cytotoxicity induced in AML cells by Vitamin D-based differentiation agents.J Steroid Biochem Mol Biol. 2017 Oct;173:139-147. doi: 10.1016/j.jsbmb.2016.09.009. Epub 2016 Sep 13. J Steroid Biochem Mol Biol. 2017. PMID: 27637326 Free PMC article.
-
Total synthesis of biologically active 20S-hydroxyvitamin D3.Steroids. 2015 Dec;104:153-62. doi: 10.1016/j.steroids.2015.09.009. Epub 2015 Oct 1. Steroids. 2015. PMID: 26433048 Free PMC article.
-
Effects of an Omega-3 and Vitamin D Supplement on Fatty Acids and Vitamin D Serum Levels in Double-Blinded, Randomized, Controlled Trials in Healthy and Crohn's Disease Populations.Nutrients. 2020 Apr 18;12(4):1139. doi: 10.3390/nu12041139. Nutrients. 2020. PMID: 32325778 Free PMC article. Clinical Trial.
-
Effects of vitamin D3 stimulation of thioredoxin-interacting protein in hepatocellular carcinoma.Hepatol Res. 2014 Dec;44(13):1357-66. doi: 10.1111/hepr.12302. Epub 2014 Mar 25. Hepatol Res. 2014. PMID: 24451003 Free PMC article.
-
The association between plasma 25-hydroxyvitamin D and subgroups in age-related macular degeneration: a cross-sectional study.PLoS One. 2013 Jul 29;8(7):e70948. doi: 10.1371/journal.pone.0070948. Print 2013. PLoS One. 2013. PMID: 23923033 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
